Our offer is intended for professional investors, particularly individuals and family offices. Our investors not only seek attractive returns but also aim to allocate their funds in businesses that have a benefit for society.
We focus on subsegments within the pharmaceutical sector that are low-risk, predictable and particularly crisis-resilient. Within these subsegments, we acquire undervalued businesses, leverage synergies and optimize asset utilization and operations to generate highly attractive returns.
Please reach out for any enquiries, we will get back to you personally and confidentially.